Penstemon digitalis the plant's cultivars is named Husker Red because of its red foliage that has white or bluish-pink flowers. The Perennial Plant Association chose the Husker Red cultivar of "Penstemon digitalis" as the 1996 Perennial Plant of the Year. The author of the book "Perennial All-Stars" described Husker Red as "a stunning flowering perennial" and that "you can easily see why the Perennial Plant Association chose this perennial above all others". Husker Red was named after the Nebraska Cornhuskers. The other cultivar, Mystica, is green at first and then later changes to red in the fall. There is a hybrid of
New Drug Application Review should complete within 6 months. The decision comes in a "Complete Response Letter". Biologics, such as vaccines and many recombinant proteins used in medical treatments are generally approved by FDA via a Biologic License Application (BLA), rather than an NDA. The manufacture of biologics is considered to differ fundamentally from that of less complex chemicals, requiring a somewhat different approval process. Generic drugs that have already been approved via an NDA submitted by another maker are approved via an Abbreviated New Drug Application (ANDA), which does not require all of the clinical trials normally required for a new drug